Suppr超能文献

胃周淋巴结状态作为胃癌患者的预后指标

Perigastric lymph node status as a prognostic indicator in patients with gastric cancer.

作者信息

Adachi Y, Suematsu T, Shiraishi N, Tanimura H, Morimoto A, Kitano S

机构信息

First Department of Surgery, Oita Medical University, Japan.

出版信息

Br J Surg. 1998 Sep;85(9):1281-4. doi: 10.1046/j.1365-2168.1998.00833.x.

Abstract

BACKGROUND

The extent of lymph node dissection and histological examination of dissected lymph nodes varies among countries, which leads to the erroneous nodal stage and different surgical results in gastric cancer (stage migration, 'Will Rogers effect'). The aim of this study was to clarify the prognostic significance of the number of positive perigastric lymph nodes, which could be evaluated simply after D1 gastrectomy.

METHODS

A consecutive series of 106 patients with histologically node-positive gastric cancer treated by radical gastrectomy and lymph node dissection (D2 or D3) was studied. The number of metastatic perigastric nodes (level I, nos 1-6) was examined, and its influence on the survival of patients was analysed.

RESULTS

The overall 5-year survival rate was 50.9 per cent; the 5-year survival rate was significantly decreased when positive perigastric nodes exceeded six (62 per cent for one to six nodes versus 23 per cent for seven or more nodes, P< 0.001). Tumours having one to six positive perigastric nodes compared with those having seven or more positive perigastric nodes were more likely to have a size less than 4 cm (29 per cent versus one of 30, P< 0.001), grossly localized type (45 per cent versus seven of 30, P=0.042), absence of serosal invasion (32 per cent versus none of 30, P=0.002) and metastasis limited to the perigastric lymph nodes (70 per cent versus seven of 30, P < 0.001).

CONCLUSION

The results indicate that the number of positive perigastric nodes correlates with tumour progression and patient survival. This parameter is a simple and useful prognostic indicator for node-positive gastric cancer, and is available not only for D2 and D3 gastrectomy but also for D1 gastrectomy.

摘要

背景

各国之间胃癌淋巴结清扫范围及清扫后淋巴结的组织学检查存在差异,这导致胃癌的淋巴结分期错误以及手术结果不同(分期迁移,“威尔·罗杰斯效应”)。本研究旨在明确胃周阳性淋巴结数量的预后意义,该数量在D1胃切除术后即可简单评估。

方法

对连续106例经根治性胃切除及淋巴结清扫(D2或D3)治疗的组织学检查证实为淋巴结阳性的胃癌患者进行研究。检查胃周转移淋巴结(第I组,第1 - 6组)数量,并分析其对患者生存的影响。

结果

总体5年生存率为50.9%;当胃周阳性淋巴结超过6个时,5年生存率显著降低(1至6个淋巴结时为62%,7个或更多淋巴结时为23%,P < 0.001)。与胃周阳性淋巴结7个或更多的肿瘤相比,胃周阳性淋巴结1至6个的肿瘤更可能具有以下特征:大小小于4 cm(29% 对30例中的1例,P < 0.001)、大体局限型(45% 对30例中的7例,P = 0.042)、无浆膜侵犯(32% 对30例中的0例,P = 0.002)以及转移局限于胃周淋巴结(70% 对30例中的7例,P < 0.001)。

结论

结果表明胃周阳性淋巴结数量与肿瘤进展及患者生存相关。该参数是淋巴结阳性胃癌简单且有用的预后指标,不仅适用于D2和D3胃切除术,也适用于D1胃切除术。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验